Odyssey Therapeutics (ODTX) Cash & Equivalents (2022 - 2026)
Odyssey Therapeutics' Cash & Equivalents was $80.64 million in Q3 2026, up 62.8% from $49.52 million a year earlier but down 1.7% from the prior quarter.
Odyssey Therapeutics (ODTX) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Odyssey Therapeutics came in at $41.69 million, down 29.5% from FY2024.
- Cash & Equivalents shows a three-year compound annual growth rate of -44.3% (FY2022 to FY2025).
- In earlier years, Cash & Equivalents was $59.14 million in FY2024 (+12.5%), $52.55 million in FY2023 (-78.2%) and $241.04 million in FY2022.
- Quarterly Cash & Equivalents has moved between $35.72 million (Q1 2026) and $241.04 million (Q4 2022) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in three of the last six quarters, with an average decline of 2.2%.
- Per Business Quant data, ODTX's Cash & Equivalents in the three quarters before Q3 2026 was $82.03 million (Q2 2026), $35.72 million (Q1 2026) and $41.69 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Odyssey Therapeutics | 929.15 Mn | -64.53 Mn | - | 80.64 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 80.64 Mn |
| Jun 30, 2026 | 82.03 Mn |
| Mar 31, 2026 | 35.72 Mn |
| Dec 31, 2025 | 41.69 Mn |
| Sep 30, 2025 | 49.52 Mn |
| Jun 30, 2025 | 163.00 Mn |
| Mar 31, 2025 | 54.91 Mn |
| Dec 31, 2024 | 59.14 Mn |
| Sep 30, 2024 | 39.44 Mn |
| Dec 31, 2023 | 52.55 Mn |
| Dec 31, 2022 | 241.04 Mn |
Odyssey Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ODTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ODTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ODTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();